- Supported exchanges /
- KQ /
- 310210.KQ
Voronoi Co. Ltd. (310210 KQ) stock market data APIs
Voronoi, Inc. researches, develops, and discovers small molecule kinase inhibitors in South Korea. Its products pipeline includes VRN01, an oral leucine rich repeat kinase 2 inhibitor targeting glioblastoma multiforme to treat brain and pancreatic cancers; VRN07, VRN06, and VRN11 for the treatment of lung cancer; VRN08 and VRN10 to treat breast cancer; and VRN02 for the treatment of rheumatoid arthritis and atopic dermatitis. The company's products pipeline also comprise VRN04-1 to treat autoimmune diseases; VRN04-2 for the treatment of multiple sclerosis and amyotrophic lateral sclerosis; VRN13 to treat pulmonary arterial hypertension; and VRN14 for the treatment of refractory solid cancer. Voronoi, Inc. was founded in 2015 and is based in Incheon, South Korea.
Voronoi Co. Ltd. Financial Data Overview
| 85100 | |
| 81000 | |
| - | |
| 85100 | |
| 80500 | |
| 28350-125900 | |
| 1 455 694 M | |
| 17 392 K | |
| 589 M | |
| -525.654 | |
| 1.828 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Voronoi Co. Ltd. Fundamental Data is available in our Financial Data APIs
- Net Revenue 589 M
- EBITDA -29 846 734 848
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Voronoi Co. Ltd. Earnings via APIs
- Latest Release 2024-09-30
- EPS/Forecast NaN
Get Voronoi Co. Ltd. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
